Pamidronate Disodium
NDC 67457-430, Pamidronate Disodium, injection, from Mylan Institutional LLC.
- Product NDC
- 67457-430
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078520
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PAMIDRONATE DISODIUM3 mg/mL
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-430-10 | 67457043010 | 1 VIAL in 1 CARTON (67457-430-10) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c2ca033e-fa5f-4141-b702-11f8b4303da1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-430
Use it
Look up 67457-430 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.